Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

ALYSSA MARTIN

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1114541117
CMS profile
10742929
Location
MODESTO, CA

General Payments · PY2022–2025

$1,883.61

  • Reported across 57 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$303.51

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $303.51 17

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $188.38 12
Novo Nordisk AS $66.81 3
AIMMUNE THERAPEUTICS, INC. $48.32 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $564.40 12
PY2023 $315.02 8
PY2024 $700.68 20
PY2025 $303.51 17

Payment records · PY2025 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2025 202220232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Aimmune Therapeutics, Inc. $18.31 02/21/2025 Food and Beverage Undisputed 06/30/2026 1249700920 CMS
Aimmune Therapeutics, Inc. $30.01 04/14/2025 Food and Beverage Undisputed 06/30/2026 1249700922 CMS
Lilly USA, LLC $6.90 01/24/2025 Food and Beverage Undisputed 06/30/2026 1187009010 CMS
Lilly USA, LLC $18.48 02/06/2025 Food and Beverage Undisputed 06/30/2026 1186962548 CMS
Lilly USA, LLC $10.37 03/25/2025 Food and Beverage Undisputed 06/30/2026 1186944155 CMS
Lilly USA, LLC $23.42 04/25/2025 Food and Beverage Undisputed 06/30/2026 1187009008 CMS
Lilly USA, LLC $7.15 04/29/2025 Food and Beverage Undisputed 06/30/2026 1186980242 CMS
Lilly USA, LLC $22.25 05/10/2025 Food and Beverage Undisputed 06/30/2026 1187058981 CMS
Lilly USA, LLC $16.64 05/12/2025 Food and Beverage Undisputed 06/30/2026 1186962550 CMS
Lilly USA, LLC $0.52 05/13/2025 Food and Beverage Undisputed 06/30/2026 1187058979 CMS
Lilly USA, LLC $8.60 06/10/2025 Food and Beverage Undisputed 06/30/2026 1186944157 CMS
Lilly USA, LLC $20.55 07/10/2025 Food and Beverage Undisputed 06/30/2026 1187069117 CMS
Lilly USA, LLC $24.86 08/29/2025 Food and Beverage Undisputed 06/30/2026 1187009012 CMS
Lilly USA, LLC $28.64 09/19/2025 Food and Beverage Undisputed 06/30/2026 1187069119 CMS
Novo Nordisk Inc $22.51 03/07/2025 Food and Beverage Undisputed 06/30/2026 1189139421 CMS
Novo Nordisk Inc $20.47 05/13/2025 Food and Beverage Undisputed 06/30/2026 1188542586 CMS
Novo Nordisk Inc $23.83 07/24/2025 Food and Beverage Undisputed 06/30/2026 1188619067 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2022, 2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.